Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation

G Wolf, S Singh, K Blakolmer, L Lerer, T Lifschytz… - Molecular …, 2023 - nature.com
Schizophrenia is a widespread psychiatric disorder that affects 0.5–1.0% of the world's
population and induces significant, long-term disability that exacts high personal and …

Brain changes associated with long-term ketamine abuse, a systematic review

JFM Strous, CJ Weeland, FA van der Draai… - Frontiers in …, 2022 - frontiersin.org
Recently, the abuse of ketamine has soared. Therefore, it is of great importance to study its
potential risks. The effects of prolonged ketamine on the brain can be observationally …

[HTML][HTML] Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2

JP Lopez, MD Lücken, E Brivio, S Karamihalev, A Kos… - Neuron, 2022 - cell.com
A single sub-anesthetic dose of ketamine produces a rapid and sustained antidepressant
response, yet the molecular mechanisms responsible for this remain unclear. Here, we …

Mechanisms of endocannabinoid control of synaptic plasticity

BL Winters, CW Vaughan - Neuropharmacology, 2021 - Elsevier
The endogenous cannabinoid transmitter system regulates synaptic transmission
throughout the nervous system. Unlike conventional transmitters, specific stimuli induce …

Chronic exposure of alcohol triggers microglia-mediated synaptic elimination inducing cognitive impairment

L Lan, H Wang, X Zhang, Q Shen, X Li, L He… - Experimental …, 2022 - Elsevier
Background and aims Long-term alcohol intake leads to cognitive impairment and dementia.
The impairment of the cerebral cortex and limbic structures in alcoholics is associated with …

Ketamine for post-traumatic stress disorders and it's possible therapeutic mechanism

M Asim, B Wang, B Hao, X Wang - Neurochemistry International, 2021 - Elsevier
Posttraumatic stress disorder (PTSD) is a devastating medical illness, for which currently
available pharmacotherapies have poor efficacy. Accumulating evidence from clinical and …

Postsynaptic proteins at excitatory synapses in the brain—relationship with depressive disorders

S Samojedny, E Czechowska… - International journal of …, 2022 - mdpi.com
Depressive disorders (DDs) are an increasingly common health problem that affects all age
groups. DDs pathogenesis is multifactorial. However, it was proven that stress is one of the …

Antidepressant mechanisms of ketamine's action: NF-κB in the spotlight

P Sokołowska, MS Karbownik… - Biochemical …, 2023 - Elsevier
Ketamine recently approved for therapy of treatment-resistant depression shows a complex
and not fully understood mechanism of action. Apart from its classical glutamatergic N …

[HTML][HTML] Hippocampal neuropathology in suicide: Gaps in our knowledge and opportunities for a breakthrough

L Zhang, PJ Lucassen, E Salta, PDEM Verhaert… - Neuroscience & …, 2022 - Elsevier
Suicide is a major global hazard. There is a need for increasing suicide awareness and
effective and evidence-based interventions, targeting both suicidal ideation and conduct …

Alterations in brain synaptic proteins and mRNAs in mood disorders: a systematic review and meta-analysis of postmortem brain studies

E Leung, EW Lau, A Liang, C de Dios, R Suchting… - Molecular …, 2022 - nature.com
The pathophysiological mechanisms underlying bipolar (BD) and major depressive
disorders (MDD) are multifactorial but likely involve synaptic dysfunction and dysregulation …